Terns Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company headquartered in Foster City, California, dedicated to developing innovative small-molecule therapies aimed at transforming the treatment landscape for nonalcoholic steatohepatitis (NASH) and other chronic liver diseases. With a diverse pipeline featuring both single-agent and combination therapy candidates, Terns is well-positioned to address pressing unmet medical needs in hepatology. The company's focus on advancing novel therapeutics not only promises to enhance patient outcomes significantly but also presents an attractive investment prospect for institutional investors keen on capitalizing on the growing market for liver disease treatments. Show more

Location: 1065 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA, UNITED STATES, 94404, Foster City, CA, 94404, USA | Website: https://www.ternspharma.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE

Market Cap

3.763B

52 Wk Range

$1.86 - $48.26

Previous Close

$34.60

Open

$34.76

Volume

1,565,412

Day Range

$34.62 - $37.03

Enterprise Value

3.425B

Cash

150.7M

Avg Qtr Burn

-19.77M

Insider Ownership

0.60%

Institutional Own.

85.01%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
TERN-701 Details Chronic myeloid leukemia (CML)	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TERN-601 (GLP-1R agonists) Details Obesity	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TERN-101 (FXR agonist) Details Non-alcoholic steatohepatitis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TERN-501 (THR-B Agonist) +/- TERN-101 (FXR agonist) Details Non-alcoholic steatohepatitis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
TERN-201 (VAP-1 inhibitor) Details Non-alcoholic steatohepatitis	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.